Back
Trulieve Cannabis Vs. Karyopharm Therapeutics Industry Stock Comparison
Sell
17
TCNNF
Trulieve Cannabis
Last Price:
5.93
Seasonality Move:
12.73%
Sell
28
KPTI
Karyopharm Therapeutics
Last Price:
0.86
Seasonality Move:
-2.8%
Sell
17
Trulieve Cannabis (TCNNF)
is a Sell
Is Trulieve Cannabis a Buy, Sell or Hold?
- The current Trulieve Cannabis [TCNNF] share price is $6.12. The Score for TCNNF is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- TCNNF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $0.78. The Score for KPTI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- KPTI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TCNNF Stock Price Chart
What is Trulieve Cannabis's stock price today?
-
The Trulieve Cannabis share price today is $6.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCNNF is experiencing slight selling pressure.
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $0.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KPTI is experiencing slight buying pressure.
TCNNF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.5 | Sell |
| Relative Strength Index (14 RSI): | 31.44 | Sell |
| Chaikin Money Flow: | -172125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.68 - 12.68) | Sell |
| Bollinger Bands (100): | (8.46 - 12.04) | Sell |
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 41.33 | Sell |
| Chaikin Money Flow: | -20521 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.81 - 0.91) | Sell |
| Bollinger Bands (100): | (0.76 - 0.92) | Sell |
TCNNF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.5 | Sell |
| 20-day SMA: | 8.86 | Sell |
| 50-day SMA: | 10.69 | Sell |
| 200-day SMA: | 10.39 | Sell |
| 8-day EMA: | 6.69 | Sell |
| 20-day EMA: | 8.23 | Sell |
| 50-day EMA: | 9.7 | Sell |
| 200-day EMA: | 9.75 | Sell |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.82 | Sell |
| 20-day SMA: | 0.86 | Sell |
| 50-day SMA: | 0.82 | Sell |
| 200-day SMA: | 1.02 | Sell |
| 8-day EMA: | 0.81 | Sell |
| 20-day EMA: | 0.84 | Sell |
| 50-day EMA: | 0.84 | Sell |
| 200-day EMA: | 1.01 | Sell |
Trulieve Cannabis Earnings Growth & TCNNF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.10 per share, and an increase next year of $0.47 per share.
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.
Trulieve Cannabis Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Karyopharm Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||